Skip to main content
    F

    FibroGen Inc (FGEN)

    Official site

    BIOTECHNOLOGY

    $9.71
    +0.69 (+7.65%)

    Last updated: Jan 07, 2026 at 4:00 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    50%(18/36)
    Avg Surprise
    -28.53%
    PeriodReportedEst.SurpriseB/MYoY
    Sep 25
    Reported Nov 10
    		$-3.25$-0.10-3321.05%Miss-22360.3%
    Jun 25
    Reported Aug 11
    		$-3.39$-0.09-3666.67%Miss-2018.8%
    Mar 25
    Reported May 5
    		$0.05$0.02+150.00%Beat+115.2%
    Dec 24
    Reported Feb 24
    		$-0.08N/A+60.00%Beat+86.0%
    Sep 24
    Reported Nov 4
    		$0.01N/A+104.87%Beat+102.8%
    Jun 24
    Reported Aug 6
    		$-0.16$-0.32+50.00%Beat+82.2%
    Mar 24
    Reported May 6
    		$-0.33$-0.42+21.43%Beat+59.3%
    Dec 23
    Reported Feb 26
    		$-0.57$-0.42-35.71%Miss+18.6%
    Sep 23
    Reported Nov 6
    		$-0.52$-0.68+23.53%Beat+46.9%
    Jun 23
    Reported Aug 7
    		$-0.90$-0.70-28.57%Miss-15.4%
    Mar 23
    Reported May 8
    		$-0.81$-0.75-8.00%Miss-19.1%
    Dec 22
    Reported Feb 27
    		$-0.70$-0.94+25.53%Beat+51.7%
    Sep 22
    Reported Nov 7
    		$-0.98$-0.81-20.99%Miss-281.5%
    Jun 22
    Reported Aug 8
    		$-0.78$-0.94+17.02%Beat+46.2%
    Mar 22
    Reported May 9
    		$-0.68$-0.83+18.07%Beat+12.8%
    Dec 21
    Reported Feb 28
    		$-1.45$-0.66-119.70%Miss-126.6%
    Sep 21
    Reported Nov 9
    		$0.54$-0.01+5500.00%Beat+54.3%
    Jun 21
    Reported Aug 9
    		$-1.45$-0.48-202.08%Miss-52.6%
    Mar 21
    Reported May 10
    		$-0.78$-0.87+10.34%Beat+12.4%
    Dec 20
    Reported Mar 1
    		$-0.64$-0.24-166.67%Miss+42.9%
    Sep 20
    Reported Nov 5
    		$0.35N/A+143.75%Beat+161.4%
    Jun 20
    Reported Aug 6
    		$-0.95$-0.64-48.44%Miss-175.4%
    Mar 20
    Reported May 7
    		$-0.89$-0.39-128.21%Miss-67.9%
    Dec 19
    Reported Mar 2
    		$-1.12$-0.59-89.83%Miss-548.0%
    Sep 19
    Reported Nov 11
    		$-0.57$-0.55-3.64%Miss-14.0%
    Jun 19
    Reported Aug 8
    		$1.26$-0.51+347.06%Beat+550.0%
    Mar 19
    Reported May 9
    		$-0.53$-0.67+20.90%Beat-6.0%
    Dec 18
    Reported Feb 27
    		$0.25$-0.10+350.00%Beat+192.6%
    Sep 18
    Reported Nov 8
    		$-0.50$-0.35-42.86%Miss+0.0%
    Jun 18
    Reported Aug 7
    		$-0.28N/A+52.54%Beat+41.7%
    Mar 18
    Reported May 9
    		$-0.50$-0.51+1.96%Beat+3.8%
    Dec 17
    Reported Feb 27
    		$-0.27$-0.28+3.57%Beat+50.0%
    Sep 17
    Reported Nov 8
    		$-0.50$-0.37-35.14%Miss-
    Jun 17
    Reported Aug 7
    		$-0.48$-0.47-2.13%Miss-
    Mar 17
    Reported May 9
    		$-0.52$-0.49-6.12%Miss-
    Dec 16
    Reported Mar 1
    		$-0.54$-0.53-1.89%Miss-

    Key Metrics

    Valuation
    P/E RatioN/AEV/EBITDAN/A
    Price/FCFN/AFCF YieldN/A
    Profitability
    Profit MarginN/AOperating MarginN/A
    ROEN/AROICN/A
    Financial Health
    Debt/EquityN/AInterest CoverageN/A
    Current RatioN/AQuick RatioN/A
    Trading Statistics
    BetaN/AAvg VolumeN/A
    52-Week HighN/A52-Week LowN/A

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$8.90
    SMA 20$8.85
    SMA 50$9.24
    SMA 200N/A
    EMA 10$9.01
    EMA 20$8.92
    EMA 50$9.22
    EMA 200$9.03

    MACD

    Line: 0.02Signal: -0.10Hist: 0.13

    ADX

    ADX: 20.2+DI: 25.7-DI: 13.2

    Aroon & PSAR

    Aroon Up44.0
    Aroon Down12.0
    PSAR$10.00

    Bollinger Bands

    Upper Band$9.75
    Lower Band$7.96
    %B Position2028%(Upper)
    Band Width0.98

    RSI (14-Day)

    Neutral
    60.1

    Momentum Oscillators

    Stoch %K53.2
    Stoch %D39.1
    Williams %R-2.8
    ROC (10d)13.4%
    Momentum1.15
    CCI (20d)154.1
    MFI (14d)44.6

    Volatility Measures

    ATR (14d)$0.55(5.6%)
    StdDev (20d)0.45
    Hist Vol92.8%(High)

    Volume Flow

    VWAP$9.56
    OBV-2.5M
    AD Line22.8B
    CMF (20d)0.051

    Volume Metrics

    Avg Vol (20d)42.3K
    Vol Ratio0.8x
    VWMA (20d)$9.32

    Pivot Points

    R3$9.75
    R2$9.54
    R1$9.28
    Pivot Point$9.07
    S1$8.81
    S2$8.60
    S3$8.34

    Advanced Oscillators

    TSI1.05
    Ultimate Osc47.4
    KST-3.75

    Financial Data

    QuarterSep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023Dec 2022
    Total Revenue$1.08M$1.35M$2.74M$-123,256,000$46.33M$998,000$25.36M$27.14M$40.13M$44.32M$36.16M$34.37M
    Cost of Revenue$-58,000$85,000$252,000$-20,666,000$5.29M$32.50M$57.83M$5.41M$4.24M$5.71M$3.49M$4.92M
    Gross Profit$1.13M$1.26M$2.49M$-102,590,000$41.04M$-31,502,000$-32,468,000$21.73M$35.89M$38.61M$32.67M$29.44M
    Operating Expenses$6.54M$13.31M$17.41M$-10,934,000$57.82M$14.91M$16.71M$75.93M$99.37M$126.66M$108.76M$95.59M
    R&D$1.21M$5.87M$9.18M$1.49M$21.71M$32.36M$36.49M$51.70M$61.19M$95.48M$74.49M$61.63M
    SG&A$5.29M$7.06M$8.11M$13.32M$17.55M$22.28M$22.82M$24.22M$25.57M$31.18M$34.27M$33.97M
    Operating Income$-5,411,000$-12,052,000$-14,920,000$-91,656,000$-16,778,000$-46,408,000$-49,182,000$-54,195,000$-63,482,000$-88,048,000$-76,091,000$-66,152,000
    Interest Income$931,000$286,000$413,000$204,000$3.80M$900,000$2.57M$2.50M$4.30M$2.65M$1.04M$924,000
    Interest Expense$2.08M$2.01M$2.26M$2.22M$4.99M$1.87M$2.09M$5.07M$5.02M$3.07M$2.37M$1.12M
    Income Before Tax$-13,146,000$-13,775,000$-16,764,000$-87,589,000$-17,072,000$-47,376,000$-49,039,000$-56,152,000$-63,531,000$-87,915,000$-76,631,000$-66,067,000
    Income Tax Expense$-213,782,000$-92,000$2,000$-52,000$12,000$-281,000$7,000$80,000$84,000$-235,000$74,000$108,000
    Net Income$200.64M$-7,603,000$4.64M$17.98M$-17,084,000$-15,544,000$-32,933,000$-56,232,000$-63,615,000$-87,680,000$-76,705,000$-66,175,000
    EBITDA$-10,871,000$-11,545,000$-14,180,000$-91,100,000$-12,237,000$-45,627,000$-48,362,000$-49,824,000$-56,808,000$-82,684,000$-72,090,000$-62,538,000
    EBIT$-11,063,000$-11,766,000$-14,507,000$-91,452,000$-12,976,000$-46,408,000$-49,182,000$-51,699,000$-59,186,000$-85,396,000$-75,055,000$-65,228,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about FGEN

    News

    No news available

    Company news will appear here when available

    FGEN Competitors

    CompanyTicker
    CVRx IncCVRX
    Cosmos Health Inc.COSM
    Scynexis IncSCYX
    Nephros IncNEPH
    Grace Therapeutics, Inc.GRCE
    Veru IncVERU
    Nano X Imaging LtdNNOX
    Harvard Bioscience IncHBIO

    Sector: Healthcare

    FGEN Earnings: Beat Rate and Next Report

    Beat rate
    5 of 8 quarters (62.5%)
    Average surprise
    -829.6%

    Frequently Asked Questions About FGEN

    Does FGEN pay dividends?

    FibroGen Inc (FGEN) does not currently pay a regular dividend.

    Related stocks

    Sector: Healthcare

    All stocks starting with F

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In